Gene expression analysis in both normal mammary epithelial and breast cancer cells revealed that PR inhibited NFκB target genes through interacting with DNA-bound RelA/p65, resulting in transcription inhibition of NFκB target genes. This evidence concerns the gene RELA and breast carcinoma.